Navigation Links
Tennessee Woman’s Biomet Metal Hip Implant Device Failed, Causing Pain, Elevated Metal Ion Levels, and the Need for Revision Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
Date:8/6/2013

New York, New York (PRWEB) August 06, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit on behalf of a Tennessee woman who alleges that her Biomet M2a Magnum hip implant device is defective and caused her injuries, as well as the need to undergo revision surgery. The suit was filed on May 30, 2013 in the U.S. District Court for the Northern District of Indiana, South Bend Division (Case No. 3:13-cv-508) and is one of many cases pending in the multidistrict litigation (MDL) entitled In re: Biomet M2a Magnum Hip Implants Products Liability Litigation (MDL No. 3:12-md-2391). Biomet, Inc. and Biomet Orthopedics, LLC have been named as Defendants.

According to the Complaint, the Plaintiff was implanted in her left hip with the M2a Magnum system on April 13, 2009. The lawsuit alleges that by the time she underwent this implant surgery, the Defendants were already aware of over 100 adverse event reports linked to the device, yet they failed to disclose this information to the Plaintiff. Instead, the suit alleges, the Defendants misrepresented the M2a Magnum implant as safe and efficacious. Allegedly, the Plaintiff’s surgeon would not have implanted the M2a Magnum had it not been for the misrepresentations made by the Defendants.

The lawsuit alleges that, as a result of the M2a Magnum’s defective design, the Plaintiff’s hip implant failed, causing her severe pain, and resulting in her suffering from elevated metal ion levels. As a result of this, she underwent a complex, risky revision surgery to explant, or remove the device, and be re-implanted with a replacement hip device. The suit alleges that revision surgeries are generally more complex than initial implantation because there is typically less bone to work with when the original device is removed from the body. Revision surgeries usually take longer to complete than the original hip surgery and have a higher rate of complications. The Plaintiff is suing for economic damages, including lost wages, as well as medical and hospital expenses; severe and possibly permanent injuries; pain; suffering; and emotional distress.

The Biomet M2a Magnum is a type of metal-on-metal hip implant. The U.S. Food and Drug Administration (FDA) has put the metal-on-metal class of medical devices under increased scrutiny following reports of high failure rates and the release of elevated concentrations of metallic debris into the bloodstream. On January 17, 2013, the FDA released new guidelines for patients who were implanted with all-metal devices. The agency also advised that regular physical examinations, diagnostic imaging, and metal ion testing be conducted in symptomatic patients.

Additionally, new data from Canada suggests that people implanted with metal-on-metal hips are likelier to have to undergo revision surgery within five years of implantation with the all-metal device, according to a July 18 CBC News report. According to the Canadian Institutes for Health Information study, people who have received metal-on-metal implants face a 5.9 percent increased likelihood of having to undergo device replacement within five years of original implantation; this, in comparison to a 2.7 percent rate among people who received metal-on-plastic implants. The all-metal implant design did not work as expected, CBC News reported. In fact, under the body’s weight during daily activity—such as walking—the implant’s metal parts rub against each other. This rubbing causes metal particles to shed into the person’s surrounding tissue and bloodstream, causing bone and tissue damage due to metallosis (metal poisoning), as well as pseudotumors and the need for early revision surgery to remove and replace the hip with implantation of another device.

Parker Waichman LLP continues to offer free legal consultations to victims of metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a metal-on-metal hip implant, please contact their office by visiting the firm's Defective Hip Implant page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/Biomet_lawsuit_Tennessee/08/prweb11003130.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Basketball Legend Pat Summitt Leaving as Tennessee Womens Coach
2. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
3. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
4. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
5. Tennessee Dental Association and Succeed Management Solutions Partner to Deliver New Safety Software Solution for Tennessee Dentists
6. AED.com Donates LifePak CR Plus AED to Tennessee State University Athletic Department
7. University of Tennessee researcher finds first time could predict sexual satisfaction
8. Tennessee Hospitals Take Aim at Medical Error with Aerial Aces
9. Dr. Stephen Lazarus Is a Plastic Surgeon and Expert Injector in Knoxville, Tennessee, Offering New SkinMedica Skin Brightening Product, Lytera
10. Smith & Nephew Hip Recall News: Bernstein Liebhard LLP Notes Motion to Consolidate Smith & Nephew Lawsuits Filed in Tennessee State Courts
11. Middle Tennessee Pest Control Experts U.S. Pest Protection Launch Mobile Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: